According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are โฌ0.91 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | โฌ0.87 B | 11.73% |
2022-12-31 | โฌ0.78 B | 28.28% |
2021-12-31 | โฌ0.61 B | 113.28% |
2020-12-31 | โฌ0.28 B | 135.27% |
2019-12-31 | โฌ0.12 B | 43.37% |
2018-12-31 | โฌ85.32 M | 8.34% |
2017-12-31 | โฌ78.75 M | -6.15% |
2016-12-31 | โฌ83.91 M | 22.94% |
2015-12-31 | โฌ68.25 M | 35.56% |
2014-12-31 | โฌ50.35 M | 39.1% |
2013-12-31 | โฌ36.19 M | -17.29% |
2012-12-31 | โฌ43.76 M | -15.67% |
2011-12-31 | โฌ51.9 M | 57.1% |
2010-12-31 | โฌ33.03 M | -15.36% |
2009-12-31 | โฌ39.03 M | 42.61% |
2008-12-31 | โฌ27.37 M | -48.64% |
2007-12-31 | โฌ53.29 M | 48.57% |
2006-12-31 | โฌ35.86 M | 4.13% |
2005-12-31 | โฌ34.44 M | 1390.89% |
2004-12-31 | โฌ2.31 M | 76.48% |
2003-12-31 | โฌ1.3 M | 16.78% |
2002-12-31 | โฌ1.12 M | -56.62% |
2001-12-31 | โฌ2.58 M |